Viewing Study NCT05124561

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:00 PM
Ignite Modification Date: 2026-05-25 @ 12:54 PM
Study NCT ID: NCT05124561
Status: WITHDRAWN
Last Update Posted: 2023-06-18
First Post: 2021-11-17
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study to Evaluate the inHaled Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) On the Protective-Efficacy in Adults (SeiHOPE)
Sponsor: CanSino Biologics Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None COVID-19 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None COVID-19 View
None Vaccine View
None Inhalation View
None Ad5 View
None Efficacy View
None Safety View
None Immunogenicity View